“…The strategy used by the salmon aquaculture industry to prevent and/or limit P. salmonis infections is focused on the use of antibiotics and vaccines (Lozano, Díaz, Muñoz, & Riquelme, 2018;Maisey et al, 2016), however, existing treatments are inefficient and frequently lead to the emergence of antibiotic-resistant isolates (Martínez, Díaz-Ibarrola, et al, 2018). Comparative genomic analysis of P. salmonis has demonstrated the existence of genes that contribute to tetracycline and florfenicol resistance, resulting in more virulent and pathogenic bacterial strains compared to strains isolated from wild fish (Cartes et al, 2016;Martínez, Oyarzún, Vargas-Lagos, et al, 2017;Miller & Harbottle, 2017). To date, the impact of antibioticresistant P. salmonis strains on native Chilean fish species, including E. maclovinus, has not been totally understood.…”